Xanthigen and Its Impact on Weight and Metabolic Health (NCT07519980) | Clinical Trial Compass
RecruitingNot Applicable
Xanthigen and Its Impact on Weight and Metabolic Health
Spain180 participantsStarted 2026-02-02
Plain-language summary
Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen®) on overweight or obesity during 16 weeks of consumption.
Who can participate
Age range20 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The subject is able and willing to follow the study protocol procedures to sign the informed consent form prior to the evaluations.
* Participants must be between 20 and 50 years of age at the time of consent.
* The subject is in good physical and mental health as determined by medical history, physical examination, electrocardiogram, vital signs, biochemistry, and hematology results.
* Participants must have a BMI between 27 and 29.9 kg/cm2.
* Desire to lose weight.
Exclusion Criteria:
* Relevant medical history or presence of any medical condition that could interfere with this study, such as a previous diagnosis of diabetes, hypertension, hyperlipidemia, cardiovascular disease, thyroid disease, asthma, arthritis, or inflammatory conditions.
* Fasting blood sugar levels greater than 125 mg/dL and/or total cholesterol levels greater than or equal to 240 mg/dL.
* Blood pressure levels below 90/140 mm Hg (diastolic/systolic).
* Chronic intake of medications/dietary supplements with an impact on body weight or body composition or lipid-modifying products (e.g., protein shakes, statins, omega-3 fatty acids, etc.) 2 months prior to selection or during the study.
* Known allergy/sensitivity to any of the components of the investigational product.
* Change in hormonal contraception or any use of hormone replacement therapy (HRT) during or at least 3 months prior to the study (if female).
* Women of childbearing age who are pregnant or intend to become pregn…
What they're measuring
1
Weight
Timeframe: It will be measured at the beginning and at least once during the 4 months of consumption.
Trial details
NCT IDNCT07519980
SponsorUniversidad CatĂłlica San Antonio de Murcia